Maternal arterial stiffness in hypertensive pregnancies with and without small‐for‐gestational‐age neonate

  1. Perry, H. 13
  2. Gutierrez, J. 1
  3. Binder, J. 12
  4. Thilaganathan, B. 13
  5. Khalil, A. 13
  1. 1 Fetal Medicine Unit, St George's University Hospitals NHS Foundation Trust, University of London London UK
  2. 2 Department of Obstetrics and Fetomaternal Medicine Medical University of Vienna Vienna Austria
  3. 3 Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London London UK
Aldizkaria:
Ultrasound in Obstetrics & Amp; Gynecology

ISSN: 0960-7692 1469-0705

Argitalpen urtea: 2020

Alea: 56

Zenbakia: 1

Orrialdeak: 44-50

Mota: Artikulua

DOI: 10.1002/UOG.21893 GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Ultrasound in Obstetrics & Amp; Gynecology

Laburpena

ObjectivePregnancies complicated by pre-eclampsia with a small-for-gestational-age (SGA) neonate have poorer maternal hemodynamic function compared to those with hypertensive disorders of pregnancy (HDP) and an appropriately grown neonate. Arterial stiffness is a recognized prognostic marker of cardiovascular disease in the general population. The aim of this study was to compare maternal arterial stiffness between hypertensive pregnancies with, and those without, a SGA neonate and normotensive control pregnancies.MethodsThis was a prospective cohort study of pregnancies complicated by pre-eclampsia or gestational hypertension and healthy normotensive control pregnancies, presenting to a tertiary referral hospital between January 2012 and May 2018. Maternal arterial stiffness was assessed by aortic pulse-wave velocity (PWV) and aortic augmentation index (AIx), which were recorded using a non-invasive device (Arteriograph®). Maternal and hemodynamic factors were adjusted for using linear regression analysis. Pregnancies with HDP were divided into those that delivered a SGA (birth weight < 10th percentile) neonate (HDP + SGA group) and those that delivered an appropriately grown neonate (HDP-only group). Comparisons between groups were carried out using the Mann–Whitney U-test for continuous variables and the chi-square (or Fisher's exact) test for categorical variables.ResultsIncluded in the analysis were 69 patients with HDP who delivered a SGA neonate, 129 with HDP who delivered a normally grown neonate and 220 healthy controls. Maternal age, weight, height and heart rate were associated significantly with brachial and aortic AIx. Maternal weight, height, mean arterial pressure, heart rate and gestational age were significant predictors of aortic PWV. Adjusted aortic AIx was significantly higher in both the HDP + SGA and HDP-only groups, compared with in controls (12.5% and 10.0% vs 7.6%; both P < 0.01), and was significantly different between the two HDP groups (P = 0.002). Adjusted PWV was significantly higher in the HDP-only group compared with in controls and the HDP + SGA group (7.7 m/s vs 7.1 m/s and 7.1 m/s; both P < 0.001). Conversely, unadjusted PWV was not significantly different between the two HDP groups (P = 0.414).ConclusionsPregnancies complicated by HDP with, and those without, a SGA neonate have significantly higher aortic AIx compared with uncomplicated normotensive pregnancies. Aortic AIx was highest in those pregnancies complicated by HDP with a SGA neonate, reflecting a progression in severity of arterial stiffness abnormality with a worsening clinical picture. These findings most likely reflect systemic reduced vascular compliance and increased systemic vascular resistance in pregnancy complicated by HDP. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Erreferentzia bibliografikoak

  • 10.1161/CIRCULATIONAHA.109.192064
  • 10.1136/bmj.39335.385301.BE
  • 10.1161/HYPERTENSIONAHA.110.150078
  • 10.1136/bmj.j3078
  • 10.1161/HYPERTENSIONAHA.114.04850
  • 10.1161/CIRCULATIONAHA.111.034884
  • 10.1161/HYPERTENSIONAHA.112.194159
  • 10.1111/1471-0528.16269
  • 10.1161/01.CIR.96.1.308
  • 10.1161/CIRCULATIONAHA.104.483628
  • 10.1111/j.1471-0528.2008.01906.x
  • 10.1002/uog.7559
  • 10.1002/uog.11183
  • 10.1097/HJH.0b013e32834e4b0f
  • 10.1111/aogs.12145
  • 10.1080/10641963.2016.1254227
  • 10.1097/AOG.0b013e318197c392
  • 10.1016/j.preghy.2014.02.001
  • 10.1111/j.1471-0528.1975.tb00710.x
  • 10.1002/uog.20272
  • British and Irish Hypertension Society: How to Measure Blood Pressure: Automated Blood Pressure Measurement.https://bihsoc.org/resources/bp‐measurement/measure‐blood‐pressure/.
  • 10.1097/HJH.0b013e32833c8a1a
  • 10.1111/j.1469-7793.2000.t01-1-00263.x
  • 10.1081/PRG-200059871
  • 10.1152/ajpheart.01106.2008
  • 10.1111/j.1471-0528.2005.00701.x
  • 10.1161/CIRCULATIONAHA.110.948455
  • 10.1016/j.tcm.2018.04.009
  • 10.1161/HYPERTENSIONAHA.118.11191
  • 10.1113/jphysiol.1961.sp006686
  • 10.1093/qjmed/95.2.67
  • 10.1016/S0895-7061(01)02326-3
  • 10.1016/S0895-7061(97)00311-7
  • 10.1186/s12872-016-0303-6
  • 10.1016/j.ajog.2007.11.014
  • 10.1016/j.ajog.2017.10.226
  • 10.1161/01.HYP.37.5.1236
  • 10.1161/01.CIR.0000033824.02722.F7
  • 10.1093/ajh/hps067
  • 10.1097/HJH.0000000000000090
  • 10.1002/uog.19112
  • 10.1016/j.ajog.2018.11.1087
  • Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977–2016.
  • Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974.
  • Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010; 56: 166–171.
  • Behrens I, Basit S, Melbye M, Lykke JA, Wohlfahrt J, Bundgaard H, Thilaganathan B, Boyd HA. Risk of post-pregnancy hypertension in women with a history of hypertensive disorders of pregnancy: nationwide cohort study. BMJ 2017; 358: j3078. http://www.ncbi.nlm.nih.gov/pubmed/28701333.
  • Veerbeek JHW, Hermes W, Breimer AY, van Rijn BB, Koenen S V., Mol BW, Franx A, de Groot CJM, Koster MPH. Cardiovascular Disease Risk Factors After Early-Onset Preeclampsia, Late-Onset Preeclampsia, and Pregnancy-Induced Hypertension. Hypertension 2015; 65: 600–606.
  • Bonamy A-KE, Parikh NI, Cnattingius S, Ludvigsson JF, Ingelsson E. Birth Characteristics and Subsequent Risks of Maternal Cardiovascular Disease. Circulation 2011; 124: 2839–2846.
  • Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction. Hypertension 2012; 60: 437–443.
  • Perry H, Binder J, Gutierrez J, Thilaganathan B, Khalil A. Maternal hemodynamic function differs in preeclampsia when it is associated with a small for gestational age newborn: a prospective cohort study. BJOG 2020. DOI: 10.1111/1471-0528.16269.
  • Franklin SS, Gustin W, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–315.
  • Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A, Health ABC Study. Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults. Circulation 2005; 111: 3384–3390.
  • Khalil AA, Cooper DJ, Harrington KF. Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre-eclampsia. BJOG 2009; 116: 268–276; discussion 276–277.
  • Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound Obstet Gynecol 2010; 35: 671–679.
  • Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH. Maternal hemodynamics at 11–13 weeks' gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol 2012; 40: 28–34.
  • Hausvater A, Giannone T, Sandoval Y-HG, Doonan RJ, Antonopoulos CN, Matsoukis IL, Petridou ET, Daskalopoulou SS. The association between preeclampsia and arterial stiffness. J Hypertens 2012; 30: 17–33.
  • Franz MB, Burgmann M, Neubauer A, Zeisler H, Sanani R, Gottsauner-Wolf M, Schiessl B, Andreas M. Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies. Acta Obstet Gynecol Scand 2013; 92: 960–966.
  • Namugowa A, Iputo J, Wandabwa J, Meeme A, Buga GAB. Comparison of arterial stiffness in preeclamptic and normotensive pregnant women from a semi-rural region of South Africa. Clin Exp Hypertens 2017; 39: 277–283.
  • Khalil A, Jauniaux E, Harrington K. Antihypertensive Therapy and Central Hemodynamics in Women With Hypertensive Disorders in Pregnancy. Obstet Gynecol 2009; 113: 646–654.
  • Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens 2014; 4: 97–104.
  • Robinson HP, Fleming JE. A critical evaluation of sonar crown–rump measurements. Br J Obstet Gynaecol 1975; 82: 702–710.
  • Salomon LJ, Alfirevic Z, Da Silva Costa F, Deter RL, Figueras F, Ghi T, Glanc P, Khalil A, Lee W, Napolitano R, Papageorghiou A, Sotiriadis A, Stirnemann J, Toi A, Yeo G. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol 2019; 53: 715–723.
  • British and Irish Hypertension Society: How to Measure Blood Pressure: Automated Blood Pressure Measurement. https://bihsoc.org/resources/bp-measurement/measure-blood-pressure/.
  • Horváth IG, Németh Á, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A. Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens 2010; 28: 2068–2075.
  • Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000; 525 Pt 1(Pt 1): 263–270.
  • Rönnback M, Lampinen K, Groop P-H, Kaaja R. Pulse Wave Reflection in Currently and Previously Preeclamptic Women. Hypertens Pregnancy 2005; 24: 171–180.
  • Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH. Maternal arterial stiffness in pregnancies affected by preeclampsia. Am J Physiol Circ Physiol 2009; 297: H759–764.
  • Spasojevic M, Smith SA, Morris JM, Gallery EDM. Peripheral arterial pulse wave analysis in women with pre-eclampsia and gestational hypertension. BJOG 2005; 112: 1475–1478.
  • Yinon Y, Kingdom JCP, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney DZI, Hladunewich MA. Vascular Dysfunction in Women With a History of Preeclampsia and Intrauterine Growth Restriction. Circulation 2010; 122(18): 1846–1853.
  • Perry H, Khalil A, Thilaganathan B. Preeclampsia and the Cardiovascular System: An Update. Trends Cardiovasc Med 2018; 28: 505–513.
  • Thilaganathan B, Kalafat E. Cardiovascular System in Preeclampsia and Beyond. Hypertension 2019; 73: 522–531.
  • Bergel DH. The static elastic properties of the arterial wall. J Physiol 1961; 156: 445–457.
  • Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM 2002; 95: 67–74.
  • Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C. Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 2002; 15: 445–452.
  • Glasser S, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ, Cohn JN. Vascular Compliance and Cardiovascular Disease A Risk Factor or a Marker? Am J Hypertens 1997; 10: 1175–1189.
  • Wilenius M, Tikkakoski AJ, Tahvanainen AM, Haring A, Koskela J, Huhtala H, Kähönen M, Kööbi T, Mustonen JT, Pörsti IH. Central wave reflection is associated with peripheral arterial resistance in addition to arterial stiffness in subjects without antihypertensive medication. BMC Cardiovasc Disord 2016; 16: 131.
  • Rang S, van Montfrans GA, Wolf H. Serial hemodynamic measurement in normal pregnancy, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2008; 198: 519.e1–9.
  • Ferrazzi E, Stampalija T, Monasta L, Di Martino D, Vonck S, Gyselaers W. Maternal hemodynamics: a method to classify hypertensive disorders of pregnancy. Am J Obstet Gynecol 2018; 218: 124.e1–11.
  • Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241.
  • Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic Pulse-Wave Velocity and Its Relationship to Mortality in Diabetes and Glucose Intolerance. Circulation 2002; 106: 2085–2090.
  • Estensen M-E, Remme EW, Grindheim G, Smiseth OA, Segers P, Henriksen T, Aakhus S. Increased Arterial Stiffness in Pre-eclamptic Pregnancy at Term and Early and Late Postpartum: A Combined Echocardiographic and Tonometric Study. Am J Hypertens 2013; 26: 549–556.
  • Mahendru AA, Everett TR, Wilkinson IB, Lees CC, McEniery CM. A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J Hypertens 2014; 32: 849–856.
  • Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, Akolekar R, Konstantinidou L, Tsavdaridou M, Galeva S, Ajdacka U, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright A, Wright D, Nicolaides KH. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation. Ultrasound Obstet Gynecol 2018; 52: 186–195.
  • Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH. Predictive performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol 2019; 220: 199.e1–13.